BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27313329)

  • 41. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Viel DO; Tsuneto LT; Sossai CR; Lieber SR; Marques SB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA; Visentainer JE
    Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.
    Gruhn B; Intek J; Pfaffendorf N; Zell R; Corbacioglu S; Zintl F; Beck JF; Debatin KM; Steinbach D
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1571-7. PubMed ID: 19896081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
    Murphy N; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King B; Macgregor L; Holdsworth R; McCluskey J; Tait BD
    Bone Marrow Transplant; 2006 Apr; 37(8):773-9. PubMed ID: 16518429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myofibroblasts generated in culture from sclerotic skin lesions of a patient with extensive chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation are of recipient origin.
    Goussetis E; Spiropoulos A; Theodosaki M; Stefanaki K; Petrakou E; Graphakos S
    Stem Cells Dev; 2010 Sep; 19(9):1285-7. PubMed ID: 20001597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children.
    Kondo M; Kojima S; Horibe K; Kato K; Matsuyama T
    Bone Marrow Transplant; 2001 Apr; 27(7):727-30. PubMed ID: 11360113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
    Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
    Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation.
    Nam M; Shin S; Park KU; Kim I; Yoon SS; Kwon TK; Song EY
    Ann Lab Med; 2018 Nov; 38(6):591-598. PubMed ID: 30027704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [IL-18 single nucleotide polymorphisms in hematologic malignancies with HLA matched sibling donor allogeneic hematopoietic stem cell transplantation].
    Cai X; Song A; Wang H; Zhang P; Zhang G; Yang F; Wei J; Ma Q; Yan Z; Jiang E; Huang Y; Yang D; Wang M; He Y; Han M; Feng S
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):215-20. PubMed ID: 24666487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
    Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
    JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor.
    Lin MT; Storer B; Martin PJ; Tseng LH; Grogan B; Chen PJ; Zhao LP; Hansen JA
    Blood; 2005 Dec; 106(12):3995-4001. PubMed ID: 16109775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
    Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of IL-10 and IL-10Rbeta gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor.
    Sivula J; Turpeinen H; Volin L; Partanen J
    BMC Immunol; 2009 May; 10():24. PubMed ID: 19409109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.
    Santos N; Rodríguez-Romanos R; de la Cámara R; Brunet S; Nieto JB; Buño I; Martínez C; Jiménez-Velasco A; Vallejo C; González M; Solano C; Ferrá C; Sampol A; Pérez-Simón JA; López-Jiménez J; Díez JL; Gallardo D;
    Ann Hematol; 2018 Nov; 97(11):2217-2224. PubMed ID: 30019128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival.
    Kordelas L; Schwich E; Lindemann M; Heinemann FM; Buttkereit U; Horn PA; Beelen DW; Rebmann V
    Front Immunol; 2019; 10():3027. PubMed ID: 31998310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of cytokine gene polymorphisms on the outcome of HLA matched sibling hematopoietic stem cell transplantation.
    Kamel AM; Gameel A; Ebid GTA; Radwan ER; Mohammed Saleh MF; Abdelfattah R
    Cytokine; 2018 Oct; 110():404-411. PubMed ID: 29801972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation.
    Varney MD; Lester S; McCluskey J; Gao X; Tait BD
    Hum Immunol; 1999 Jun; 60(6):532-8. PubMed ID: 10408803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chromosome Y-encoded antigens associate with acute graft-versus-host disease in sex-mismatched stem cell transplant.
    Wang W; Huang H; Halagan M; Vierra-Green C; Heuer M; Brelsford JE; Haagenson M; Scheuermann RH; Telenti A; Biggs W; Pearson NM; Udell J; Spellman S; Maiers M; Kennedy CJ
    Blood Adv; 2018 Oct; 2(19):2419-2429. PubMed ID: 30262602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation.
    Lorenz E; Schwartz DA; Martin PJ; Gooley T; Lin MT; Chien JW; Hansen JA; Clark JG
    Biol Blood Marrow Transplant; 2001; 7(7):384-7. PubMed ID: 11529488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.
    Qin XY; Wang Y; Li GX; Qin YZ; Wang FR; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    J Transl Med; 2016 Apr; 14():100. PubMed ID: 27118383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
    Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
    Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.